Custom service

Linkers and Spacers

Insert cleavable or non-cleavable linkers and spacers of defined length

Turnaround: 2–5 weeksTypical scale: 0.5 mg – 1 g modified peptideChemistry options: PEG and alkyl spacers (C2–C24); cleavable motifs (Val-Cit, disulfide, hydrazone); click-ready bifunctional linkers

Linkers and Spacers supports programmes that insert cleavable or non-cleavable linkers and spacers of defined length. In a typical engagement we plan the PEG and alkyl spacers (C2–C24) route first, confirm compatibility with cleavable motifs (Val-Cit, disulfide, hydrazone), and release linker-modified construct with spacer confirmation on a 2–5 weeks schedule.

Chemistry is chosen for the molecule, not from a menu. Where the payload tolerates it we keep PEG and alkyl spacers (C2–C24) as the primary option and hold cleavable motifs (Val-Cit, disulfide, hydrazone) in reserve, so that scale-up never depends on an unproven step.

Tuning payload-to-carrier distance in conjugates

Protease-cleavable prodrug linkers

Linker chemistries requiring licensed proprietary IP

Modifications requiring radiological or BSL-3 containment

Modified peptides are released against a specification that includes site occupancy. Where a modification is labile (sulfation, glycosylation, phosphorylation), we use fragmentation data rather than mass shift alone to assign the site, and we state detection limits for any positional isomers that co-elute.

Service Highlights

  • PEG and alkyl spacers (C2–C24) as the default route, with cleavable motifs (Val-Cit, disulfide, hydrazone) held as a proven fallback
  • Click-ready bifunctional linkers worked into the design where the application requires it
  • Modification sites are mapped on the sequence and confirmed by MS/MS before release
  • Analytical confirmation of every intermediate before the final release
  • Modified and unmodified species are separated and quantified, not just reported
  • Linker-modified construct with spacer confirmation delivered with a complete conjugation or synthesis certificate

How the work runs

  1. Sequence & modification map

    We annotate every modification site, protection strategy and analytical target before synthesis starts.

  2. Solid-phase assembly

    The chain is built with Fmoc chemistry, inserting modified or unnatural residues at the mapped positions.

  3. Modification chemistry

    Post-synthesis steps — PEG and alkyl spacers (C2–C24), cleavable motifs (Val-Cit, disulfide, hydrazone) — are run under conditions validated on a test cleavage.

  4. Cleavage & purification

    Global deprotection and cleavage are followed by RP-HPLC purification to the agreed purity.

  5. Analytical release

    Purity, identity and modification ratio are confirmed by HPLC, MS and MS/MS site mapping.

  6. Documentation

    Linker-modified construct with spacer confirmation is released with the batch record and analytical package after QC sign-off.

Specifications & timeline

Turnaround
2–5 weeks
Typical scale
0.5 mg – 1 g modified peptide
Chemistry options
PEG and alkyl spacers (C2–C24); cleavable motifs (Val-Cit, disulfide, hydrazone); click-ready bifunctional linkers
Deliverable
Linker-modified construct with spacer confirmation
QC package
HPLC purity, ESI/MALDI MS, MS/MS site mapping, modification ratio
Shipping
Ambient or blue ice as stability data dictate

Related Products

Next step

Tell us the target, we will tell you what is feasible

Send the sequence, assay format and sensitivity you need. You will get a technical assessment — recommended platform, timeline and the risks worth knowing before you commit budget.